ORAL TOPICAL TIMOLOL MALEAT OR ORAL PROPRANOLOL TREATMENT FOR INFANTILE HEMANGIOMAS: CLINICAL ANALYSIS OF 403 PATIENTS

Objective: Infantile hemangiomas (IH) are the most common benign vascular tumors of infancy. Propranolol (P), a nonselective beta-blocker, has been successfully used in managing IHs. Ongoing studies investigate the efficacy of the topical β-antagonist timolol maleate (TM) in IHs. The aim of this stu...

Full description

Bibliographic Details
Published in:	Sanamed
Main Authors:	Terzi Özlem, Arslantaş Esra, Baş Nur Cennet, Kaçar Gonca Ayşe, Uysalol Pasli Ezgi, Solgun Avni Hüseyin, Yıldırgan Duygu, Karagenç Özkan Ayşe, Ertürk Saide, Ayçiçek Ali
Format:	Article
Language:	English
Published:	Association of medical doctors Sanamed Novi Pazar 2023-09-01
Subjects:	timolol maleate infantile hemangioma propranolol
Online Access:	https://new.sanamed.rs/pdf/18_2/584-3104-1-PB.pdf

Similar Items

Symptomatic Bradycardia and Syncope due to Ophthalmic Timolol Maleate
by: Muge Gulen, et al.
Published: (2014-08-01)

Effects of Latanoprost 0.005%/Timolol Maleate 0.5% and Dorzolamide 2%/Timolol Maleate 0.5% Fixed Combinations on 24-hour Intraocular Pressure in Patients with Primary Open-Angle Glaucoma
by: Berna Yüce, et al.
Published: (2012-01-01)

Topical timolol maleate in the treatment of mixed and deep infantile hemangiomas: a report of two cases
by: Momcilo Pavlovic, et al.
Published: (2024-09-01)

Clinical and Dermoscopic evaluation of post acne erythema after treatment with topical timolol maleate 0.5%
by: Sawen Jihanger Omer, et al.
Published: (2024-06-01)

Two Stability Indicating Chromatographic Methods: TLC Densitometric versus HPLC Method for the Simultaneous Determination of Brinzolamide and Timolol Maleate in Ophthalmic Formulation in the Presence of Probable Carcinogenic Oxidative Degradation Product of Timolol Maleate
by: Asmaa A. Mandour, et al.
Published: (2023-01-01)

Evaluation of Transdermal Transport and Concurrent Cutaneous Hydrolysis of Timolol Prodrug for the Treatment of Infantile Hemangiomas
by: Shih-Jen Chang, et al.
Published: (2022-08-01)

Efficacy and safety of oral propranolol and topical timolol in the treatment of infantile hemangioma: a meta-analysis and systematic review
by: Xiaoye Huang, et al.
Published: (2024-12-01)

Efficacy of Combined Topical Timolol and Oral Propranolol for Treating Infantile Hemangioma: A Meta-Analysis of Randomized Controlled Trials
by: Junbo Qiao, et al.
Published: (2020-10-01)

Insights into the interaction of Fibrinogen with Timolol Maleate and elucidation of binding sites via. spectroscopic and molecular docking study
by: Neha Govind Rao, et al.
Published: (2025-08-01)

Simultaneous spectrofluorometric analysis of tablets containing hydrochlorothiazide combined with timolol maleate or amiloride hydrochloride
by: Wedian Fadel, et al.
Published: (2020-09-01)

Determination of related substances of travoprost in travoprost and timolol maleate eye drops by HPLC
by: LI Yujun, et al.
Published: (2025-06-01)

Magnesium Hydroxide Nanoparticles Improve the Ocular Hypotensive Effect of Twice Daily Topical Timolol Maleate in Healthy Dogs
by: Mizuki Kita, et al.
Published: (2021-08-01)

Transdermal delivery of timolol maleate using hydrogel microneedles for the treatment of infantile haemangiomas
by: Xiaokun Lin, et al.
Published: (2025-06-01)

First-order derivative spectrophotometric method for simultaneous determination of brinzolamide and timolol maleate in ophthalmic formulation
by: Srushti Tambe, et al.
Published: (2024-03-01)

Poly(Sulfobetaine Methacrylate-co-Vinyl Pyrrolidone) Hydrogels as Potential Contact Lenses Delivery Systems for Timolol Maleate
by: Denitsa Nikolova, et al.
Published: (2023-01-01)

Effect of dacryocystorhinostomy on systemic adverse effects of topical timolol maleate
by: Kakoli Roy, et al.
Published: (2012-01-01)

Effects of timolol maleate eye drops on experimentally dilated cardiomyopathy and healthy rabbits
by: Mitsuhiro Isaka, et al.
Published: (2021-08-01)

Dorzolamide Hydrochloride %2 and Timolol Maleate %0.5 Fixed Combination in Lowering Intraocular Pressure after Phacoemulsification cataract Surgery
by: Abdulrahman Alaa Makki, et al.
Published: (2023-02-01)

Efficacy of 0.5% Timolol Maleate versus 0.05% Clobetasol Propionate in Treating Superficial Infantile Hemangioma: A Pilot Randomized Controlled Trial
by: Sunita Singh, et al.
Published: (2025-05-01)

Current Approach to The Treatment of Infantile Hemangioma
by: Aybüke Doğan, et al.
Published: (2023-03-01)

Preparation and testing of buffered eye drops containing pilocarpine chloride with timolol maleate
by: Rakić Danijela, et al.
Published: (2006-01-01)

Ocular Co-Delivery of Timolol and Brimonidine from a Self-Assembling Peptide Hydrogel for the Treatment of Glaucoma: In Vitro and Ex Vivo Evaluation
by: Elissavet Taka, et al.
Published: (2020-06-01)

To compare intralesional and oral propranolol for treating periorbital and eyelid capillary hemangiomas
by: Aditi Mehta, et al.
Published: (2019-01-01)

Oral Propranolol Administration in Treatment of Hemangiomas: An Update
by: Rahşan Özcan, et al.
Published: (2017-12-01)

Comparative study of brimonidine and timolol in treatment of glaucoma
by: Jagadish Chandrarao Narasaiah Lakkineni
Published: (2015-01-01)

Efeitos maleato de timolol 0.5% do cloridrato de dorzolamida 2%, e da associação de ambas na pressão intra-ocular Efficacy of timolol maleate 0.5% dorzolamide hydrochloride 2%, and the combination of both drugs on intraocular pressure
by: A.G. Borges, et al.
Published: (2007-06-01)

Oral propranolol therapy in 23 infants with infantile hemangioma
by: Jaeyoon Kim, et al.
Published: (2018-11-01)

Oral Propranolol for Treatment of Pediatric Capillary Hemangiomas
by: Maryam Aletaha, et al.
Published: (2012-01-01)

Post combined surgery- A rare case of ocular hypotony
by: Sathyan Parthasathi, et al.
Published: (2023-01-01)

Safe and Effective Treatment of Intracranial Infantile Hemangiomas with Beta-Blockers
by: Aoife Naughton, et al.
Published: (2021-07-01)

Oral atenolol compared to oral propranolol for infantile hemangioma
by: Victor Meza Viteri, et al.
Published: (2023-12-01)

Timing of treatment with oral propranolol for infantile hemangioma
by: Kaizhi Zhang, et al.
Published: (2025-09-01)

Comprehensive review of analytical techniques for evaluating fixed-dose combinations containing timolol
by: Imad O. Abu Reid, et al.
Published: (2025-05-01)

Hyperkalemia due to topical timolol for hemangioma
by: Bushra Alasmari, MBBS, et al.
Published: (2023-09-01)

Excellent Response of Infantile Hemangioma with Oral Propranolol: A Case Report
by: Armyta Denissafitri, et al.
Published: (2022-11-01)

Infantile Haemangioma in the Romanian Paediatric Population—Characteristics and Therapeutic Approaches
by: Anca-Maria Raicu, et al.
Published: (2023-07-01)

Timolol versus latanoprost for primary open-angle glaucoma
by: Nilo Vincent dG. FlorCruz II, MD, et al.
Published: (2005-06-01)

Quantitative Analysis of Dimetindene Maleate in Dosage Forms by Ion-pair Reversed- Phase HPLC
by: Kahtan Jassim Hasson
Published: (2014-12-01)

Retrospective Evaluation of an Oral Propranolol Delivery Strategy in 25 Cases of Infantile Hemangioma
by: Shinichi Ashizawa, et al.
Published: (2024-04-01)

Characterization of Liquid Dosage Forms of Atenolol and Enalapril Maleate for Oral and Enteral Feeding Administration
by: Sandra Mota, et al.
Published: (2024-08-01)